MegaRobo raises $200M for AI-driven lab automation
Chinese biotech robotics firm MegaRobo has raised $200 million in new funding, bringing its total to $600 million. Founded in 2016, the company builds robotic systems that allow AI software to run physical experiments. Investors include Oman Investment Authority, Granite Asia, Sinovation Ventures and CMB International. Its flagship platform, Megalaxy Lab, makes real-world experimentation programmable, enabling AI agents to configure experiments, track execution and feed results into further scientific reasoning. MegaRobo is also launching Poreva Open, a global AI protein design challenge, with wet-lab validation for over 10,000 protein design sequences.
